{"id":"W2086142513","doi":"10.3816/clc.2001.n.018","title":"Phase I Study of the BLP25 (MUC1 Peptide) Liposomal Vaccine for Active Specific Immunotherapy in Stage IIIB/IV Non–Small-Cell Lung Cancer","year":2001,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":162,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta; Alberta Cancer Foundation","funders":"","keywords":"Medicine; Immunotherapy; Vaccination; Immunogenicity; Lung cancer; Cancer vaccine; Immunology; Immune system; Peptide vaccine; Internal medicine; MUC1; Cancer; Oncology; Gastroenterology; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001102054,0.001289393,0.00148242,0.0004271232,0.00050306,0.0008887575,0.0008678408,0.001311674,0.002039367],"category_scores_gemma":[0.0004077767,0.0005505421,0.0007815713,0.0002543309,0.0009631495,0.0006645353,0.0003393099,0.002522872,0.0005918462],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009610664,"about_ca_system_score_gemma":0.001631153,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002454275,"about_ca_topic_score_gemma":0.002656922,"domain_scores_codex":[0.9996845,0.00008925563,0.00001079278,0.00005293913,0.0000307353,0.0001317722],"domain_scores_gemma":[0.999697,0.00004042916,0.00003913529,0.00003029917,0.00002613559,0.0001671666],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3199468,0.1596449,0.003852447,0.0009678261,0.0009377901,0.0005823686,0.0006967347,0.006870681,0.3853117,0.00103982,0.006419745,0.1137292],"study_design_scores_gemma":[0.1470294,0.795991,0.007488121,0.00003603139,0.0003955491,0.0002664551,0.000103265,0.002545923,0.0420705,0.0002880586,0.003752562,0.00003314458],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994772,0.00110326,0.0007564148,0.0002626728,0.0001285311,0.001545607,0.0004433366,0.00006510995,0.00092312],"genre_scores_gemma":[0.9940832,0.0007273051,0.0008635248,0.0002717854,0.00007429535,0.001097152,0.0008168363,0.00001861982,0.00204727],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002454275,"threshold_uncertainty_score":0.006973028,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03284774457342199,"score_gpt":0.3810141725328872,"score_spread":0.3481664279594652,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}